» Articles » PMID: 32390938

General Adaptation in Critical Illness: Glucocorticoid Receptor-alpha Master Regulator of Homeostatic Corrections

Overview
Specialty Endocrinology
Date 2020 May 12
PMID 32390938
Citations 27
Authors
Affiliations
Soon will be listed here.
Abstract

In critical illness, homeostatic corrections representing the culmination of hundreds of millions of years of evolution, are modulated by the activated glucocorticoid receptor alpha (GRα) and are associated with an enormous bioenergetic and metabolic cost. Appreciation of how homeostatic corrections work and how they evolved provides a conceptual framework to understand the complex pathobiology of critical illness. Emerging literature place the activated GRα at the center of all phases of disease development and resolution, including activation and re-enforcement of innate immunity, downregulation of pro-inflammatory transcription factors, and restoration of anatomy and function. By the time critically ill patients necessitate vital organ support for survival, they have reached near exhaustion or exhaustion of neuroendocrine homeostatic compensation, cell bio-energetic and adaptation functions, and reserves of vital micronutrients. We review how critical illness-related corticosteroid insufficiency, mitochondrial dysfunction/damage, and hypovitaminosis collectively interact to accelerate an anti-homeostatic active process of natural selection. Importantly, the allostatic overload imposed by these homeostatic corrections impacts negatively on both acute and long-term morbidity and mortality. Since the bioenergetic and metabolic reserves to support homeostatic corrections are time-limited, early interventions should be directed at increasing GRα and mitochondria number and function. Present understanding of the activated GC-GRα's role in immunomodulation and disease resolution should be taken into account when re-evaluating how to administer glucocorticoid treatment and co-interventions to improve cellular responsiveness. The activated GRα interdependence with functional mitochondria and three vitamin reserves (B1, C, and D) provides a rationale for co-interventions that include prolonged glucocorticoid treatment in association with rapid correction of hypovitaminosis.

Citing Articles

Critical illness-related corticosteroid insufficiency (CIRCI) - an overview of pathogenesis, clinical presentation and management.

Sobolewska J, Dzialach L, Kuca P, Witek P Front Endocrinol (Lausanne). 2024; 15:1473151.

PMID: 39574948 PMC: 11580036. DOI: 10.3389/fendo.2024.1473151.


Pilot investigations into the mechanistic basis for adverse effects of glucocorticoids in dysferlinopathy.

Lloyd E, Crew R, Haynes V, White R, Mark P, Jackaman C Skelet Muscle. 2024; 14(1):19.

PMID: 39123261 PMC: 11312411. DOI: 10.1186/s13395-024-00350-6.


Physiologically Based Pharmacokinetic Modeling: The Reversible Metabolism and Tissue-Specific Partitioning of Methylprednisolone and Methylprednisone in Rats.

Yu R, Jusko W Drug Metab Dispos. 2024; 52(7):662-672.

PMID: 38653502 PMC: 11185821. DOI: 10.1124/dmd.124.001711.


Context is key: glucocorticoid receptor and corticosteroid therapeutics in outcomes after traumatic brain injury.

Taylor M, Kokiko-Cochran O Front Cell Neurosci. 2024; 18:1351685.

PMID: 38529007 PMC: 10961349. DOI: 10.3389/fncel.2024.1351685.


Prolonged intensive care: muscular functional, and nutritional insights from the COVID-19 pandemic.

Martinez-Camacho M, Jones-Baro R, Gomez-Gonzalez A, Lugo-Garcia D, Astorga P, Melo-Villalobos A Acute Crit Care. 2024; 39(1):47-60.

PMID: 38303585 PMC: 11002617. DOI: 10.4266/acc.2023.01284.


References
1.
Paupe V, Prudent J . New insights into the role of mitochondrial calcium homeostasis in cell migration. Biochem Biophys Res Commun. 2017; 500(1):75-86. PMC: 5930976. DOI: 10.1016/j.bbrc.2017.05.039. View

2.
Sinha A, Hollingsworth K, Ball S, Cheetham T . Improving the vitamin D status of vitamin D deficient adults is associated with improved mitochondrial oxidative function in skeletal muscle. J Clin Endocrinol Metab. 2013; 98(3):E509-13. DOI: 10.1210/jc.2012-3592. View

3.
Choi H, Jo S, Kim S, Lee J, Cho E, Hyun Y . Glucocorticoids attenuate septic acute kidney injury. Biochem Biophys Res Commun. 2013; 435(4):678-84. DOI: 10.1016/j.bbrc.2013.05.042. View

4.
Psarra A, Hermann S, Panayotou G, Spyrou G . Interaction of mitochondrial thioredoxin with glucocorticoid receptor and NF-kappaB modulates glucocorticoid receptor and NF-kappaB signalling in HEK-293 cells. Biochem J. 2009; 422(3):521-31. DOI: 10.1042/BJ20090107. View

5.
Gordon B, Parker T, Levine D, Saal S, Wang J, SLOAN B . Relationship of hypolipidemia to cytokine concentrations and outcomes in critically ill surgical patients. Crit Care Med. 2001; 29(8):1563-8. DOI: 10.1097/00003246-200108000-00011. View